The Petri Dish: Biogen's CEO search stalls again; A setback for Verve
The FDA ordered a pause to the development Verve Therapeutics' base-editing gene therapy.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Rowan Walrath Source Type: news